Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries

US7935339B2 · kind B2 · utility

Assignee

• DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE

Inventors

• Ana Martin-Villalba · Heidelberg, DE
• Peter Krammer · Heidelberg, DE
• Deana Demjen · Heidelberg, DE

Key dates

• Filing date: Feb 10, 2004
• Grant date: May 3, 2011
• Expiry date: Apr 1, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2039/505
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of inhibitors of the CD95 ligand/receptor system for the manufacture of a medicament for the treatment of neurological disorders or injuries in a mammal, particularly for the treatment of spinal cord injury, more particularly for the treatment of paraplegia.